Global Virus Network

11/11/2025

📢 Tomorrow: Wednesday, November 12, 2025 at 1:00 PM ET!

Join Gisa Gerold, PhD (Institute of Virology, Medical University of Innsbruck, Austria) for
“Replication of Re-emerging Arthritogenic Alphaviruses: To Bend or Not to Bend”, part of the Forefront of Virology Webinar Series.

🎓 Free & open to the public. CME credits available.
🔗 Register: https://ow.ly/TGe950XjUZG

11/10/2025

Join us in Tampa, Florida · March 2–6, 2026 for International Science Innovation Week 2026, a global gathering of leaders in science, medicine, and innovation dedicated to advancing pandemic preparedness, virology, and cancer research.

The week features the GVN Annual International Scientific Meeting – “Pandemic Preparedness?” (March 4–6), bringing together world-renowned virologists and public health experts to explore emerging threats, surveillance breakthroughs, and innovations in vaccines, therapeutics, and diagnostics.

Register now: https://ow.ly/Lngq50XowFx
Learn more: https://ow.ly/stpO50XowFu

11/10/2025

Today is World HTLV-1 Day, a time to raise awareness of Human T-cell Leukemia Virus Type 1 (HTLV-1), a virus that continues to affect millions of people around the world yet often goes unnoticed.

HTLV-1, first discovered by GVN Co-Founder Dr. Robert Gallo and colleagues, was the first human retrovirus ever identified. It is associated with serious illnesses such as blood cancer, known as T-cell leukemia/lymphoma (ATL).

According to the World Health Organization, HTLV-1 infection can persist for life and spread through blood exposure, sexual contact, or from mother to child. Despite its global reach, access to testing, prevention, and treatment remains limited.

GVN supports worldwide efforts to increase awareness, strengthen research, and promote prevention to address HTLV-1 and its related diseases.

Learn more: https://ow.ly/O3tZ50XnYTw | https://ow.ly/xEt750XnYTy

11/09/2025

🔬 Experience virology in action at the GVN Short Course (Dec 3–12, Tampa + online).

Beyond lectures, participants will:
• Tour the USF Health Virology Institute
• Visit the USF College of Public Health Insectary Lab
• Explore the Hospital AI Command Center
• Engage with the Florida Dept. of Health Public Health Labs
• Learn at the Hillsborough County Dept. of Health
• Participate in a pandemic preparedness simulation

🤝 Combine real-world learning with mentorship and networking.

⏳ Applications open until Nov 14 for online attendance (in-person applications are closed).

🔗 Apply and see the full agenda: https://ow.ly/5FMi50WRv59

11/08/2025

Bioengineering spotlights the GVN’s expansion across the Americas with the addition of three new Centers of Excellence, each advancing multidisciplinary research and pandemic preparedness.

The USF Health-University of South Florida Institute for Translational Virology and Innovation (USA), led by Dr. Robert C. Gallo, co-founder of the GVN, pioneers translational research on viruses that drive cancer, immune dysfunction, and chronic disease.

The Department of Microbiology, Immunology and Parasitology (Unifesp - Universidade Federal de São Paulo, Brazil), led by Dr. Luiz Mário Ramos Janini, advances molecular diagnostics, genomic surveillance, and epidemic response in Latin America.

The Pathogen Research Centre (PaRC) (Western University, Canada) , directed by Drs. Eric J. Arts, Richard Gibson, and Miguel E. Quiñones-Mateu, leverages advanced containment labs and transmission modeling to study viral evolution and control.

Read more: https://ow.ly/VcnJ50Xl8is

The Global Virus Network (GVN) has expanded its international coalition by incorporating three distinguished Centers of Excellence located in the Americas, broadening its capacity to address pressing

11/07/2025

News Medical highlights the GVN’s addition of three new Centers of Excellence, expanding its global reach and strengthening capacity to address viral threats across the Americas.

The new centers include:
- USF Health-University of South Florida Institute for Translational Virology and Innovation (USA)
- The Department of Microbiology, Immunology and Parasitology (Unifesp - Universidade Federal de São Paulo, Brazil)
- Pathogen Research Centre (PaRC) (Western University, Canada)

Together, these additions reinforce GVN’s commitment to advancing research, education, and preparedness against HIV, arboviruses, respiratory viruses, and emerging pathogens.

Read more: https://ow.ly/Qvsf50Xl7YN

The Global Virus Network (GVN), a coalition of leading medical virologists representing 80+ Centers of Excellence and Affiliates in 40+ countries, today announced the addition of three new Centers of Excellence: the USF Health Institute for Translational Virology and Innovation at the University of....

11/06/2025

A growing measles crisis threatens to reverse decades of progress in North America.

Gizmodo reports that Canada is expected to lose its measles-free status after a year of continuous outbreaks. This places the United States at risk of the same outcome in early 2026.

Dr. Sten Vermund, Chief Medical Officer of the GVN, told Gizmodo that “Canada will very likely lose its measles elimination status, while the United States is also at substantial risk in the next three months.”

The resurgence underscores the global consequences of declining vaccination rates, misinformation, and weakened surveillance systems. As Dr. Vermund notes, regaining control will require targeted vaccination drives, public education, and strong public health infrastructure, tools that remain as vital now as ever.

Read the full article: https://ow.ly/nxXt50Xl7Ow

After a year of ongoing outbreaks, Canada is expected to lose its measles-free status. Experts say the U.S. is on track for the same fate.

11/05/2025

📢 Next week: Wednesday, November 12, 2025 at 1:00 PM ET!

Join Gisa Gerold, PhD (Institute of Virology, Medical University of Innsbruck, Austria) for
“Replication of Re-emerging Arthritogenic Alphaviruses: To Bend or Not to Bend”, part of the Forefront of Virology Webinar Series.

🎓 Free & open to the public. CME credits available.
🔗 Register: https://ow.ly/TGe950XjUZG

11/04/2025

The University of South Florida (USF) has launched the USF Health-University of South Florida Institute for Translational Virology and Innovation, founded and directed by world-renowned scientist Dr. Robert C. Gallo, best known as co-discoverer of HIV as the cause of AIDS.

The new institute will advance cutting-edge research to combat viral and immune-related threats, from HIV and virus-associated cancers to mosquito-borne and pandemic pathogens, through translational science and cross-sector collaboration.

The institute also serves as a Center of Excellence of the GVN, which has established its international headquarters at USF, co-located with the institute in Tampa.

Under Dr. Gallo’s leadership, the institute integrates virology, oncology, genomics, and immunology to accelerate discovery, innovation, and preparedness, translating science into solutions for global health.

Read more: https://ow.ly/WNlG50Xl7zV

The groundbreaking USF Health Institute for Translational Virology and Innovation will advance cutting-edge research to combat viral and immune-related threats worldwide.

11/03/2025

Today is International One Health Day, a reminder that the health of humans, animals, and the environment is deeply interconnected.

In a world of growing public health threats, the One Health approach helps us break down barriers between sectors to better prevent, detect, and respond to disease outbreaks.

GVN supports the One Health approach as essential to protecting global health.

Learn more: https://www.who.int/southeastasia/news/speeches/detail/one-health-day | https://www.who.int/health-topics/one-health =tab_1

11/03/2025

University of Miami Miller School of Medicine highlights a major milestone for the HIV/AIDS and Emerging Infectious Diseases Institute (HEIDI), celebrating ten years of discovery and continued progress toward an HIV/AIDS cure.

At a recent event, Dr. Mario Stevenson, Director of HEIDI and Co-Director of the Miami Center for AIDS Research (CFAR), a Global Virus Network (GVN) Center of Excellence, joined Dr. Robert Gallo and Dr. Ronald Desrosiers to discuss the next frontier in HIV research, including gene therapy breakthroughs aimed at “one-and-done” treatments.

With strong backing from the State of Florida, Miami-Dade County, and philanthropic partners, HEIDI continues to drive innovation from the lab to the community, transforming the vision of a world without HIV/AIDS into a tangible scientific goal.

Read more: https://ow.ly/kMJP50XizGW

The Miller School institute marked 10 years of research progress and outlined future steps toward an HIV/AIDS cure.